Cellular Immunotherapy & SynBio

Our mission is to pioneer cutting-edge genetic technologies inspired by the mechanisms of the immune system, with the goal of developing advanced cell therapies for a broad spectrum of diseases. Leveraging the latest tools in synthetic biology—including logic gates, genetic switches, and genetic adjuvants—we strive to design programmable, precise, and safe therapeutic solutions that redefine the boundaries of personalized medicine.

Dr Hadas Weinstein-Marom

Cellular Immunotherapy and Synthetic Biology Lab at MIGAL Institute is focused on two major research arms: 

  • adoptive T cell therapy of cancer, developing new logic gated strategies, genetic switches and composite adjuvants for accurate, selective and effective immunotargeting of tumors; 
  • genetic engineering of regulatory T cells and their reprogramming for the treatment of selected inflammatory and autoimmune diseases.

Principal Researcher

Latest Publications

No publications found

Lab News